Funds holding PHARMACYTE BIOTECH INC
ISIN US71715X2036 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- 109.7K $
- Share of capital
- 1.5 % of 10.7M shares on Jul 24, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 54,986 | 37.9K $ | 0.00 % | 0.51 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 51,467 | 34.2K $ | 0.48 % | as of Mar 31, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 26,211 | 18.1K $ | 0.00 % | 0.24 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 15,256 | 10.5K $ | 0.14 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 12,896 | 8.9K $ | 0.12 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 5 | 0 | 160,816 | +9.4 % |
| 2026Q1 | 5 | 0 | 146,992 | -0.3 % |
| 2025Q4 | 5 | -4 | 147,408 | -51.8 % |
| 2025Q3 | 9 | 0 | 305,729 | -11.3 % |
| 2025Q2 | 9 | 0 | 344,691 | -1.2 % |
| 2025Q1 | 9 | 0 | 349,040 | -4.4 % |
| 2024Q4 | 9 | -3 | 364,918 | -12.2 % |
| 2024Q3 | 12 | -2 | 415,420 | -1.1 % |
| 2024Q2 | 14 | 0 | 420,212 | -0.7 % |
| 2024Q1 | 14 | 0 | 423,149 | -2.4 % |
| 2023Q4 | 14 | 433,679 |
Institutional managers
29 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| CITADEL ADVISORS LLC | 359,547 | 239.2K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 195,660 | 130.2K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 56,500 | 37.6K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 52,362 | 34.8K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 37,532 | 25 $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 35,601 | 23.7K $ | as of Mar 31, 2026 |
| Schonfeld Strategic Advisors LLC | 27,009 | 18K $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 24,741 | 16 $ | as of Mar 31, 2026 |
| EQUITEC PROPRIETARY MARKETS, LLC | 22,227 | 14.8K $ | as of Mar 31, 2026 |
| SIMPLEX TRADING, LLC | 19,940 | 13.3K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 16,360 | 10.9K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 11,530 | 7.7K $ | as of Mar 31, 2026 |
| Ground Swell Capital, LLC | 11,527 | 7.7K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 10,313 | 6.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 4,889 | 3.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,519 | 3K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 1,785 | 1.2K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 302 | 200 $ | as of Mar 31, 2026 |
| Sachetta, LLC | 14 | 10 $ | as of Mar 31, 2026 |
| Western Wealth Management, LLC | 13 | 9 $ | as of Mar 31, 2026 |
| BFSG, LLC | 5 | 4 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 3 | 2 $ | as of Mar 31, 2026 |
| FINANCIAL CONSULATE, INC | 2 | 2 $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1 | 1 $ | as of Mar 31, 2026 |
| CWM, LLC | 1 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding PHARMACYTE BIOTECH INC". https://titelia.com/en/stocks/pharmacyte-biotech-inc-US71715X2036